Hyporesponsiveness to intradermal administration of hepatitis B vaccine in insulin dependent diabetes mellitus

Archives of Disease in Childhood

Volumn 78, Issue 1, 1998, Pages 54-57

  Li Volti, S ^a   Caruso Nicoletti, M ^a   Biazzo, F ^b   Sciacca, A ^a   Mandara G ^a   Mancuso, M ^a   Mollica, F ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b GARIBALDI HOSPITAL   (Italy)

Author keywords

Cell mediated immunity; Hepatitis B vaccine; Hyporesponsiveness

Indexed keywords

HEPATITIS B VACCINE;

ADOLESCENT; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEPATITIS B; HUMAN; IMMUNOREACTIVITY; INSULIN DEPENDENT DIABETES MELLITUS; INTRADERMAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; VACCINATION;

EID: 7144261041     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.78.1.54     Document Type: Article

References (21)

1. Madalinski K, Brzosko W, Malewski M, et al. Australian antigen in sera of diabetic patients. Lancet 1971;i:701-2.
2. Polish LB, Shapiro CN, Boner F, et al. Nosocomial transmission of hepatitis B virus associated with use of a spring-loaded finger-stick device. N Engl J Med 1992;326: 721-5.
3. Pozzilli P, Arduini P, Visalli M, et al. Reduced protection against hepatitis B virus following vaccination in patients with type 1 (insulin-dependent) diabetes. Diabetologia 1987;30:817-9.
4. Wismans PJ, von Hattum J, de Gast GC, et al. A prospective study of in vitro anti-HBs producing B-cells (Spot-ELISA) following primary and supplementary vaccination with recombinant hepatitis B vaccine in insulin dependent diabetic patients and matched controls. J Med Virol 1991;35:216-22.
5. Palla G, Calisti L, Crespin L, et al. Vaccinazione anti-epatite B in un gruppo di bambini con diabete mellito insulino dipendente: valutazione della risposta anticorpale e following a 6 e 12 mesi. Riv Ital Ped Prev Soc 1994;44:176.
6. Craven DE, Awdeh ZL, Knuches LM, et al. Non responsiveness to hepatitis B vaccine in health care workers. Ann Intern Med 1986;105:355-60.
7. Alper CA, Krunskall MS, Margus-Bagley D, et al. Genetic prediction of non response to hepatitis B vaccine. N Engl J Med 1989;321:708-12.
8. Walker M, Szmuness W, Stevens C, et al. Genetics of anti-hepatitis Bs responsiveness HLA-DR7 and non-responsiveness to hepatitis vaccination. Proceedings of the American Association of Blood Banks 1981;5:601 (abstract 21).
9. Egea H, Iglesias A, Salazar M, et al. The cellular basis for lack of antibody response to hepatitis B vaccine in humans. J Exp Med 1991;173:531-5.
10. Miller KD, Gibbs RD, Mulligan MM, et al. Intradermal hepatitis B virus vaccine: immunogenicity and side-effects in adults. Lancet 1983;ii:1454-6.
11. Bryan JP, Sjogren MH, Perine PL, et al. Low-dose intradermal and intramuscular vaccination against hepatitis B. Acta Paediatr 1992;81:935-6.
12. Nagafuchi S, Kashiwagi S, Okada K, et al. Reversal of non-responders and postexposure prophylaxis by intradermal hepatitis B vaccination in japanese medical personnel. JAMA 1991;265:2679-83.
13. Leonardi S, Leggio T, Sciacca A, et al. Intradermal hepatitis B vaccination in thalassemia. Arch Dis Child 1990;65:527-9.
14. Pozzilli P, Zuccarini O, Tavicoli M, et al. Monoclonal antibodies define abnormalities of T lymphocyte subsets in diabetes. Diabetes 1983;32:91-4.
15. Drell DW, Notkins AL. Multiple immunological abnormalities in patients with type 1 (insulin-dependent diabetes mellitus. Diabetologia 1987;30:132-43.
16. Lorini R, Montagna D, Lanfranchi A, et al. Alterations of in vitro interleukin 1 and 2 in diabetic children. Eur J Pediatr 1989;148:732-4.
17. Paul WE. The immune system: introduction. In: Wingaarden JB, Smith LH, eds. Cecil textbook of medicine. Philadelphia: WB Saunders, 1990:1932-7.
18. Sahdev I, Fort P, Herry A. Macrophage-released interleukin-1 in patients with type 1 diabetes mellitus. Acta Paediatr 1992;81:935-6.
19. Bellanti JA, Rocklin RE. Cell-mediated immune reactions. In: Bellanti JA, ed. Immunology III. Philadelphia: WB Saunders, 1985:176-88.
20. Pozzilli P, Pagani S, Arduini P, et al. In vivo determination of cell mediated immune response in diabetic patients using a multiple intradermal antigen dispenser. Diabetes Res 1987; 6:5-8.
21. Savagnone E. Studio multicentrico sul rischio infettivo del diabetico. Nota I. Correlazione tra alterato metabolismo glicidico e cutireattivita al Multitest IMC. Minerva Endocrinol 1991;16:119-25.